Filter By Category
Archives
EVAZARSEN
Generic Name: EVAZARSEN
ABSTRACT -
Evazarsen is best handled as an oligonucleotide therapeutic. Its activity is sequence-specific and is not represented by a single small-molecule bond-line drawing.
DOSAGE -
Dose is sequence, chemistry, and route specific. Administer only per protocol or label.
SIDE EEFECTS -
- Injection-site reaction
- Flu-like symptoms or fatigue
- Headache
- Platelet or coagulation abnormalities may occur with some oligonucleotides
- Renal or hepatic laboratory changes
ALLERGIC REACTIONS -
These symptoms may indicate an allergic reaction and require medical attention.
- Hypersensitivity to oligonucleotide or formulation excipients
- Rash, urticaria, dyspnea, or anaphylaxis
DRUG INTERACTIONS-
- Anticoagulants or antiplatelets may require closer monitoring if platelet effects occur
- Nephrotoxic medicines may increase renal monitoring needs
- Immunomodulators may alter immune tolerability
PREAUTONS–
- Confirm sequence, chemistry, and target transcript
- Monitor renal function, liver tests, platelets, and injection reactions
- Evaluate pregnancy risk and contraception requirements
WARNINGS –
- Potential immune stimulation or complement activation
- Not interchangeable with other oligonucleotide products



. Developed by